Search research articles
Contact Us
Filters
Showing results (51-60 of 104) with videos related to
Page
of 11
Sort By:
Journal of Neuropathology and Experimental Neurology
|
May 1, 1995
Overexpression of TGF-beta 1 in the central nervous system of transgenic mice results in hydrocephalus
E Galbreath, S J Kim, K Park, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 1, 1994
Modulation of axon diameter and neurofilaments by hypomyelinating Schwann cells in transgenic mice
J S Cole, A Messing, J Q Trojanowski, et al.
Nature
|
August 1, 1985
SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice
R D Palmiter, H Y Chen, A Messing, et al.
Nature
|
August 1, 1985
Peripheral neuropathies, hepatocellular carcinomas and islet cell adenomas in transgenic mice
A Messing, H Y Chen, R D Palmiter, et al.
Gene Therapy
|
November 3, 1998
Metabolic engineering as therapy for inborn errors of metabolism--development of mice with phenylalanine hydroxylase expression in muscle
C O Harding, K Wild, D Chang, et al.
Journal of Neuroscience Research
|
August 11, 1998
Astrocytes cultured from transgenic mice carrying the added human glial fibrillary acidic protein gene contain Rosenthal fibers
L F Eng, Y L Lee, H Kwan, et al.
Genesis (New York, N.Y. : 2000)
|
October 23, 2001
hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo
L Zhuo, M Theis, I Alvarez-Maya, et al.
Annals of the New York Academy of Sciences
|
December 10, 1999
P0-Cre transgenic mice for inactivation of adhesion molecules in Schwann cells
M L Feltri, M D'Antonio, S Previtali, et al.
Journal of Neuropathology and Experimental Neurology
|
July 20, 1999
Studies in transgenic mice indicate a loss of connexin32 function in X-linked Charcot-Marie-Tooth disease
A Abel, L J Bone, A Messing, et al.
Annals of the New York Academy of Sciences
|
December 10, 1999
Peripheral nerve dysmyelination due to P0 glycoprotein overexpression is dose-dependent
A Quattrini, M L Feltri, S Previtali, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 104) with videos related to
Sort By:
Page
of 11
Journal of Neuropathology and Experimental Neurology
|
May 1, 1995
Overexpression of TGF-beta 1 in the central nervous system of transgenic mice results in hydrocephalus
E Galbreath, S J Kim, K Park, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 1, 1994
Modulation of axon diameter and neurofilaments by hypomyelinating Schwann cells in transgenic mice
J S Cole, A Messing, J Q Trojanowski, et al.
Nature
|
August 1, 1985
SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice
R D Palmiter, H Y Chen, A Messing, et al.
Nature
|
August 1, 1985
Peripheral neuropathies, hepatocellular carcinomas and islet cell adenomas in transgenic mice
A Messing, H Y Chen, R D Palmiter, et al.
Gene Therapy
|
November 3, 1998
Metabolic engineering as therapy for inborn errors of metabolism--development of mice with phenylalanine hydroxylase expression in muscle
C O Harding, K Wild, D Chang, et al.
Journal of Neuroscience Research
|
August 11, 1998
Astrocytes cultured from transgenic mice carrying the added human glial fibrillary acidic protein gene contain Rosenthal fibers
L F Eng, Y L Lee, H Kwan, et al.
Genesis (New York, N.Y. : 2000)
|
October 23, 2001
hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo
L Zhuo, M Theis, I Alvarez-Maya, et al.
Annals of the New York Academy of Sciences
|
December 10, 1999
P0-Cre transgenic mice for inactivation of adhesion molecules in Schwann cells
M L Feltri, M D'Antonio, S Previtali, et al.
Journal of Neuropathology and Experimental Neurology
|
July 20, 1999
Studies in transgenic mice indicate a loss of connexin32 function in X-linked Charcot-Marie-Tooth disease
A Abel, L J Bone, A Messing, et al.
Annals of the New York Academy of Sciences
|
December 10, 1999
Peripheral nerve dysmyelination due to P0 glycoprotein overexpression is dose-dependent
A Quattrini, M L Feltri, S Previtali, et al.
Page
of 11